Matching-adjusted comparison of oral corticosteroid reduction in asthma: Systematic review of biologics.

"CONFLICTS OF INTEREST A. Bourdin received personal fees, nonfinancial support, and other support from AstraZeneca, Novartis, Chiesi Pharmaceuticals, and Actelion; grants, personal fees, and other support from GSK; grants, personal fees, nonfinancial support, and other support from Boehringer Ingelheim; personal fees and other support from Teva and Regeneron; other support from Gilead; and personal fees and nonfinancial support from Roche, outside the submitted work. D. Husereau is a board or advisory committee member for GSK and AstraZeneca and has received financial support from AstraZeneca. N. Molinari has nothing to declare. S. Golam, L. Lindner, and X. Xu are full‐time employees of AstraZeneca. MK Siddiqui is an employee of PARAXEL International and performed the analysis on behalf of AstraZeneca. PRIOR DISCLOSURE An abstract describing these results was presented as a poster at the European Respiratory Society (ERS) International Congress 2019."

"Funding information"